Synvivia

Cognition IP drafted Synvivia’s initial biotech patent application within weeks and conducted a patentability search on new technologies to direct the company’s IP portfolio development.

Rejuvenation Technologies

Rejuvenation Technologies needed several patent applications to be filed with limited resources before a crucial fundraising round. Cognition IP delivered within a matter of weeks before the fundraising milestone. The company has since engaged for freedom-to-operate searches and ongoing portfolio development.

Tradewind BioScience

Tradewind BioScience needed to understand the IP landscape before deciding if time and resources should be dedicated to a new target. Cognition IP prepared a freedom-to-operate opinion which allowed the company to make a more compelling pitch to investors during a critical fundraising round.